Acacia Research Corporation
CombiMatrix to become independent public company
Published in Physician Law Weekly, February 8th, 2006
Acacia expects to complete the transaction in the second quarter of 2006 subject to receiving a satisfactory tax opinion from legal counsel and completing the required filings with the U.S. Securities and Exchange Commission. If the conditions are met, Acacia will redeem all of the issued and outstanding shares of Acacia Research-CombiMatrix common stock (CBMX) for all of the common stock of CombiMatrix Corporation, which will register its stock under the Securities Act of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
Source: Physician Law Weekly (2006-02-08)
More Articles from Physician Law Weekly
- Advanced BioPhotonics Inc.
Medical imaging company restructures and reduces board of directors - AngioDynamics, Inc.
Peter J. Graham appointed to board of directors at cardiology-focused device firm - Antisense Therapeutics
Approval granted to restart phase IIa trial of antisense compound in MS patients - Aperio Technologies
Microscopy systems company hires regulatory affairs executive - Bioterrorism
Law firm introduces report on new Terrorism Risk Insurance Extension Act - Bristol Royal Infirmary and General Hospital
Use of Komesaroff vaporizer lowers cost of basal flow sevoflurane anesthesia - More from this issue of Physician Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
